Free press releases distribution network?

Agency / Source: Global Vision, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Persistent Systems Showcases Pharma Solution Featuring Global Vision - Paxpro Compliance-based Design to Print Automation Solution Now Integrated with Global Vision’s Automated Proofreading Technologies (BSE & NSE: PERSISTENT) - PersistentSys.com / GlobalVisionInc.com
Persistent Systems Showcases Pharma Solution Featuring Global Vision

 

PRZOOM - /newswire/ - Montréal, Québec, Canada, 2013/02/26 - Paxpro Compliance-based Design to Print Automation Solution Now Integrated with Global Vision’s Automated Proofreading Technologies (BSE & NSE: PERSISTENT) - PersistentSys.com / GlobalVisionInc.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Persistent Systems (BSE & NSE: PERSISTENT), the global leader in software product and technology services today announced that the company will showcase its market leading Paxpro Design to Print (D2P) Automation Solutions for regulated industries, integrated with Global Vision’s suite of automated proofreading solutions. The integrated offering is being showcased at the Pharma Packaging and Labeling USA 2013 conference being held February 26 and 27 at the Hilton Philadelphia City Avenue Hotel.

“We are delighted to offer the pharmaceutical marketplace this tightly integrated joint solution as it provides packaging and QA specialists with exceptional control of their inspection and approval processes around labeling and artwork management,” said Ram Pazhayannur, VP Paxpro, a Persistent Systems Business Unit. “Global Vision’s complementary suite of solutions, validated for the pharmaceutical industry, was the clear choice for us, considering their leadership position in the inspection solution space.”

“We are excited to be working together with a D2P and PLM industry leader like Paxpro,” said Reuben Malz, President of Global Vision. “Pharmaceutical packaging and labeling is a complex process with multiple languages and SKUs that brand owners need to manage. By adding integrated proofreading solutions within the packaging workflow, the risk to the brand is greatly reduced.”

Persistent Systems will host technical demonstrations of its PaxPharma solution integrated with Global Vision’s inspection tools for text, artwork and print at the conference. PaxPharma and Global Vision’s Docu-Proof™, Digital-Page™ and ScanTVST™ solutions are both available immediately for purchase.

About Persistent Systems
Established in 1990, Persistent Systems (BSE & NSE: PERSISTENT) is a global company specializing in software product and technology services. For more than two decades, Persistent has been an innovation partner for the world’s largest technology brands, leading enterprises and pioneering start-ups. With a global team of more than 6,000 employees, Persistent has 300 customers spread across North America, Europe, and Asia. Today, Persistent focuses on developing best-in-class solutions in four key next-generation technology areas: Cloud Computing, Mobility, Analytics and Collaboration, for telecommunications, life sciences, consumer packaged goods, banking & financial services and healthcare verticals.

Paxpro, by Persistent Systems (persistentsys.com), is an Enterprise Collaboration Solution that helps integrate the Design to Print (D2P) supply-chain process, across pharmaceutical, food and beverage, health and beauty, telecom and other regulated industries. Paxpro solutions provide the backbone for brand managers to get their products released to market faster, error free and at costs significantly lower than with traditional ERP and PLM systems. Global brands across the world rely on Paxpro for their D2P processes, which are delivered securely over the cloud and in compliance with standards including 21 CFR Part 11 and GMP.

About Global Vision
Global Vision (globalvisioninc.com) is the world leader in the design and delivery of automated proofreading solutions. Its complete suite of advanced solutions featuring text-based, pixel-based and Braille inspection technologies are designed to eliminate printed artwork, text verification, and text comparison related errors, providing end-to-end security at every stage of the workflow process.

Global Vision solutions are widely interoperable and have received commercial endorsement from the world’s leading Pharmaceutical, Consumer Packaged Goods (CPG), and Artwork Management companies.

Headquartered in Montreal, Canada, Global Vision has worldwide representation.
All trademarks, trade names, service marks, and logos referenced herein belong to their respective companies.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Global Vision, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Persistent Systems Showcases Pharma Solution Featuring Global Vision

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Press Office - GlobalVisionInc.com 
514-624-4422 mspooner[.]globalvisioninc.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Global Vision, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Global Vision, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology
Ipsen Completes Acquisition of ONIVYDE® (irinotecan liposome injection) and Additional Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
Ipsen Announces MHRA Approval of New Indication for Decapeptyl® for the Treatment of Pre-menopausal Women with Early Stage Breast Cancer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  MagLar, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today